PDSB · PDS Biotechnology Corp
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements.”View the 10-Q filed Aug 13, 2026
Positioning
Aug 21, 2026 · 6 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 2.5k | 15 | 0.1% | 0 | $0.05 | $2.40 | -0.59 | 1483.8% | 3 | 43 | |
| 7 | 7 | — | — | $0.07 | $4.90 | -1 | 0.1% | 1 | 0 | |
| 5 | 5 | — | — | $0.07 | $7.40 | -0.737 | 1575.2% | 1 | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Aug 11, 2026–Aug 13, 2026. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.